TABLE 3.
Disease Free Survival | Overall Survival | |||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
Tested variables | P | HR | 95% CI | P | P | HR | 95% CI | P |
Diagnostic biopsy type | ||||||||
Wide excision biopsy | 0.691 | 1.00 | – | 0.204 | 0.500 | 1.00 | – | 0.765 |
Narrow excision biopsy | 0.360 | 0.71 | 0.39–1.28 | 0.255 | 0.315 | 0.74 | 0.37–1.51 | 0.411 |
Excision biopsy with positive margins | 0.870 | 0.59 | 0.29–1.18 | 0.132 | 0.748 | 0.75 | 0.34–1.65 | 0.476 |
Incision biopsy | 0.581 | 0.47 | 0.19–1.16 | 0.101 | 0.387 | 0.74 | 0.29–1.89 | 0.530 |
Gender | 0.018 | 1.15 | 0.70–1.89 | 0.573 | 0.004 | 1.44 | 0.81–2.57 | 0.215 |
Age (years) | 0.004 | 1.02 | 1.00–1.04 | 0.018 | 0.002 | 1.03 | 1.01–1.05 | 0.007 |
Site of primary melanoma | ||||||||
Lower extremity | 0.091 | 1.00 | – | 0.023 | 0.153 | |||
Upper extremity | 0.825 | 0.91 | 0.41–2.01 | 0.809 | 0.071 | |||
Head/Neck | 0.014 | 3.40 | 1.45–7.97 | 0.005 | 0.095 | |||
Trunk | 0.731 | 0.93 | 0.54–1.61 | 0.790 | 0.063 | |||
Breslow thickness (mm) | ||||||||
0 < x ≤ 1 | <0.001 | 1.00 | – | <0.001 | <0.001 | 1.00 | – | 0.001 |
1 < x ≤ 2 | 0.003 | 13.19 | 1.77–98.41 | 0.012 | 0.016 | 8.15 | 1.07–62.19 | 0.043 |
2 < x ≤ 4 | <0.001 | 34.11 | 4.50–258.60 | 0.001 | <0.001 | 21.43 | 2.79–164.84 | 0.003 |
> 4 | <0.001 | 15.73 | 1.86–132.81 | 0.011 | <0.001 | 11.85 | 1.35–103.70 | 0.025 |
Type of melanoma | <0.001 | 1.58 | 0.95–2.62 | 0.078 | <0.001 | 1.57 | 0.88–2.79 | 0.128 |
Ulceration | <0.001 | 1.83 | 1.09–3.07 | 0.023 | <0.001 | 1.64 | 0.89–3.04 | 0.116 |
Lymphatic invasion | <0.001 | 3.98 | 2.05–7.72 | <0.001 | <0.001 | 2.19 | 1.07–4.48 | 0.032 |
Sentinel node status | <0.001 | 3.87 | 2.23–6.70 | <0.001 | <0.001 | 3.19 | 1.75–5.81 | <0.001 |